DCN was identified as a renal cancer prognostic marker with lower levels of its protein identified in glomeruli cells of normal kidneys whereas higher levels of SPARC was predicted in glomeruli and lower levels in tubuli cells of normal kidneys. The gene discussed is DCN; the disease is renal carcinoma.